Nasus Pharma to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Nasus Pharma (NYSE: NSRX) announced management will present at three investor conferences in late February and March 2026, with CEO Dan Teleman as the company speaker.

Events: Oppenheimer Healthcare Life Sciences (Feb 25, virtual), BIO Investment & Growth Summit (Mar 2, Miami), Citizens Life Sciences (Mar 11, Miami). Management is available for one-on-one meetings.

Argus Feb 20 session

+18.00% close to close 2.0x rel. volume Open Argus

Details

News Market Reaction – NSRX

On Feb 20, the day this news came out, NSRX closed 18.00% above the previous close. That session’s volume was 2.0x the stock’s average daily volume.

Data tracked by StockTitan Argus for the Feb 20 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March.

Oppenheimer 36th Annual Healthcare Life Sciences Conference

• Date and time: February 25, 2026, 1:20 p.m. ET
• Location: Virtual (register here: https://event.summitcast.com/view/CTtthLh2Bi2D9aYoKpvtEv/KoYPJS8x3zqMuXPHfEHoSY)
• Format: Company presentation
• Speaker: Dan Teleman, Chief Executive Officer

BIO Investment & Growth Summit

• Date and time: March 2, 2026, 10:15 a.m. ET
• Location: Miami, FL
• Format: Company presentation
• Speaker: Dan Teleman, Chief Executive Officer

Citizens Life Sciences Conference

• Date and time: March 11, 2026, 3:25 p.m. ET
• Location: Miami, FL
• Format: Company presentation
• Speaker: Dan Teleman, Chief Executive Officer

Nasus management will be available for one-on-one meetings during the conferences. Interested parties should contact their conference representative to arrange a meeting.

About Nasus Pharma
Nasus Pharma is a clinical-stage pharmaceutical company developing a number of intranasal powder products addressing acute medical conditions in the community. NS002, Nasus’ intranasal powder Epinephrine product candidate is being developed as a needle-free alternative to Epinephrine autoinjectors for patients with anaphylaxis. Intranasal administration is most suitable for those situations in which rapid drug delivery is required and offers needle-free, easy-to-use alternatives. Nasus’ proprietary powder-based intranasal (“PBI”) technology is designed for rapid and reliable drug delivery, leveraging the nasal cavity’s rich vascular network for quick absorption. The PBI formulation uses uniform spherical powder particles for broad dispersion and potentially faster, higher absorption compared to liquid-based nasal products. For further information about the Company, please visit www.nasuspharma.com or follow on Twitter (X) or LinkedIn.

Company Contact
Nasus Pharma Ltd.
info@nasuspharma.com

Investor Contact
Mike Moyer
LifeSci Advisors
+1-617-308-4306
mmoyer@lifesciadvisors.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Nasus Pharma (NSRX) present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference?

Nasus Pharma will present on February 25, 2026 at 1:20 p.m. ET. According to the company, CEO Dan Teleman will deliver the virtual presentation and management will be available for one-on-one follow-up meetings with investors.

What are the details for Nasus Pharma's (NSRX) BIO Investment & Growth Summit presentation?

Nasus Pharma is scheduled to present on March 2, 2026 at 10:15 a.m. ET in Miami. According to the company, CEO Dan Teleman will speak and management will offer one-on-one meetings arranged through conference representatives.

Where and when will Nasus Pharma (NSRX) speak at the Citizens Life Sciences Conference?

Nasus Pharma will present on March 11, 2026 at 3:25 p.m. ET in Miami. According to the company, CEO Dan Teleman will be the presenter and the team will be available for investor meetings during the event.

How can investors arrange one-on-one meetings with Nasus Pharma (NSRX) management at the conferences?

Investors should contact their conference representative to arrange meetings with Nasus Pharma management. According to the company, management will be available for one-on-one meetings at the listed events and scheduling goes through the conference organizers.

Will Nasus Pharma (NSRX) offer a virtual option for its conference presentation in February 2026?

Yes, the Oppenheimer presentation on February 25, 2026 will be delivered virtually at 1:20 p.m. ET. According to the company, the virtual format allows remote attendance and includes the CEO presentation and follow-up meeting opportunities.

Who will present on behalf of Nasus Pharma (NSRX) at the investor conferences in Feb–Mar 2026?

CEO Dan Teleman will present for Nasus Pharma at all listed conferences in February and March 2026. According to the company, Dan Teleman will lead the company presentations and meet with investors one-on-one as available.